Osteopontin splice variants expressed by breast tumors regulate monocyte activation via MCP-1 and TGF-β1
Osteopontin (OPN), a multifunctional glycoprotein, has three transcripts that have distinct roles in tumors in vitro. Whether OPN transcripts have different functions in tumor processes in vivo is unclear. It has been reported that immune cell-derived OPN can promote tumor formation. We propose a hy...
Saved in:
Published in | Cellular & molecular immunology Vol. 10; no. 2; pp. 176 - 182 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
China
Nature Publishing Group
01.03.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Osteopontin (OPN), a multifunctional glycoprotein, has three transcripts that have distinct roles in tumors in vitro. Whether OPN transcripts have different functions in tumor processes in vivo is unclear. It has been reported that immune cell-derived OPN can promote tumor formation. We propose a hypothesis that tumor-derived OPN may facilitate tumor immune escape by affecting immune cell differentiation and function. In this study, we constructed lentiviral expression vectors of OPN transcripts and transfected them into the MCF-7 cell line. MCF-7 cells transfected with OPN transcripts were injected into the armpit of nude mice, and tumor growth was monitored. The results showed that all OPN transcripts promoted local tumor formation, but that there was no significant difference among transcripts. We also investigated the effect of the OPN expressed by tumor cells on monocyte differentiation by coculturing monocytes with tumor supernatant. We found OPN-c upregulated CD163 levels compared with OPN-a and OPN-b; however, none of the transcripts affected HLA-DR and CD206 levels. All OPN transcripts significantly inhibited TNF-α and enhanced IL-10 production by monocytes. Furthermore, we found that the overexpression of OPN transcripts significantly upregulated TGF-β1 and MCP-1 production by tumor cells. Using neutralizing antibody and recombinant cytokines, we found that OPN overexpressed by tumor cells regulates the production of TNF-α and IL-10 by monocytes partly via MCP-1 and TGF-β1, respectively. Collectively, our results show that OPN transcripts have no distinct role in breast cancer formation in vivo. We also demonstrate that OPN regulates the alternative activation of monocytes via TGF-β1 and MCP-1, which may represent an additional mechanism for tumor immune escape. |
---|---|
AbstractList | Osteopontin (OPN), a multifunctional glycoprotein, has three transcripts that have distinct roles in tumors in vitro. Whether OPN transcripts have different functions in tumor processes in vivo is unclear. It has been reported that immune cell-derived OPN can promote tumor formation. We propose a hypothesis that tumor-derived OPN may facilitate tumor immune escape by affecting immune cell differentiation and function. In this study, we constructed lentiviral expression vectors of OPN transcripts and transfected them into the MCF-7 cell line. MCF-7 cells transfected with OPN transcripts were injected into the armpit of nude mice, and tumor growth was monitored. The results showed that all OPN transcripts promoted local tumor formation, but that there was no significant difference among transcripts. We also investigated the effect of the OPN expressed by tumor cells on monocyte differentiation by coculturing monocytes with tumor supernatant. We found OPN-c upregulated CD163 levels compared with OPN-a and OPN-b; however, none of the transcripts affected HLA-DR and CD206 levels. All OPN transcripts significantly inhibited TNF-α and enhanced IL-10 production by monocytes. Furthermore, we found that the overexpression of OPN transcripts significantly upregulated TGF-β1 and MCP-1 production by tumor cells. Using neutralizing antibody and recombinant cytokines, we found that OPN overexpressed by tumor cells regulates the production of TNF-α and IL-10 by monocytes partly via MCP-1 and TGF-β1, respectively. Collectively, our results show that OPN transcripts have no distinct role in breast cancer formation in vivo. We also demonstrate that OPN regulates the alternative activation of monocytes via TGF-β1 and MCP-1, which may represent an additional mechanism for tumor immune escape. Osteopontin (OPN), a multifunctional glycoprotein, has three transcripts that have distinct roles in tumors in vitro. Whether OPN transcripts have different functions in tumor processes in vivo is unclear. It has been reported that immune cell-derived OPN can promote tumor formation. We propose a hypothesis that tumor-derived OPN may facilitate tumor immune escape by affecting immune cell differentiation and function. In this study, we constructed lentiviral expression vectors of OPN transcripts and transfected them into the MCF-7 cell line. MCF-7 cells transfected with OPN transcripts were injected into the armpit of nude mice, and tumor growth was monitored. The results showed that all OPN transcripts promoted local tumor formation, but that there was no significant difference among transcripts. We also investigated the effect of the OPN expressed by tumor cells on monocyte differentiation by coculturing monocytes with tumor supernatant. We found OPN-c upregulated CD163 levels compared with OPN-a and OPN-b; however, none of the transcripts affected HLA-DR and CD206 levels. All OPN transcripts significantly inhibited TNF-α and enhanced IL-10 production by monocytes. Furthermore, we found that the overexpression of OPN transcripts significantly upregulated TGF-β1 and MCP-1 production by tumor cells. Using neutralizing antibody and recombinant cytokines, we found that OPN overexpressed by tumor cells regulates the production of TNF-α and IL-10 by monocytes partly via MCP-1 and TGF-β1, respectively. Collectively, our results show that OPN transcripts have no distinct role in breast cancer formation in vivo. We also demonstrate that OPN regulates the alternative activation of monocytes via TGF-β1 and MCP-1, which may represent an additional mechanism for tumor immune escape. Osteopontin (OPN), a multifunctional glycoprotein, has three transcripts that have distinct roles in tumors in vitro . Whether OPN transcripts have different functions in tumor processes in vivo is unclear. It has been reported that immune cell-derived OPN can promote tumor formation. We propose a hypothesis that tumor-derived OPN may facilitate tumor immune escape by affecting immune cell differentiation and function. In this study, we constructed lentiviral expression vectors of OPN transcripts and transfected them into the MCF-7 cell line. MCF-7 cells transfected with OPN transcripts were injected into the armpit of nude mice, and tumor growth was monitored. The results showed that all OPN transcripts promoted local tumor formation, but that there was no significant difference among transcripts. We also investigated the effect of the OPN expressed by tumor cells on monocyte differentiation by coculturing monocytes with tumor supernatant. We found OPN-c upregulated CD163 levels compared with OPN-a and OPN-b; however, none of the transcripts affected HLA-DR and CD206 levels. All OPN transcripts significantly inhibited TNF-α and enhanced IL-10 production by monocytes. Furthermore, we found that the overexpression of OPN transcripts significantly upregulated TGF-β1 and MCP-1 production by tumor cells. Using neutralizing antibody and recombinant cytokines, we found that OPN overexpressed by tumor cells regulates the production of TNF-α and IL-10 by monocytes partly via MCP-1 and TGF-β1, respectively. Collectively, our results show that OPN transcripts have no distinct role in breast cancer formation in vivo . We also demonstrate that OPN regulates the alternative activation of monocytes via TGF-β1 and MCP-1, which may represent an additional mechanism for tumor immune escape. |
Author | Jintang Sun Alei Feng Songyu Chen Yun Zhang Qi Xie Meixiang Yang Qianqian Shao Jia Liu Qifeng Yang Beihua Kong Xun Qu |
AuthorAffiliation | Institute of Basic Medical Sciences, Jinan, China Department of Obstetrics and Gynecology, Jinan, China Key Laboratory of Cardiovascular Proteomics of Shandong Province, Qilu Hospital, Shandong University, Jinan, China |
Author_xml | – sequence: 1 givenname: Jintang surname: Sun fullname: Sun, Jintang organization: Institute of Basic Medical Sciences, Jinan, China – sequence: 2 givenname: Alei surname: Feng fullname: Feng, Alei – sequence: 3 givenname: Songyu surname: Chen fullname: Chen, Songyu – sequence: 4 givenname: Yun surname: Zhang fullname: Zhang, Yun – sequence: 5 givenname: Qi surname: Xie fullname: Xie, Qi – sequence: 6 givenname: Meixiang surname: Yang fullname: Yang, Meixiang – sequence: 7 givenname: Qianqian surname: Shao fullname: Shao, Qianqian – sequence: 8 givenname: Jia surname: Liu fullname: Liu, Jia – sequence: 9 givenname: Qifeng surname: Yang fullname: Yang, Qifeng – sequence: 10 givenname: Beihua surname: Kong fullname: Kong, Beihua – sequence: 11 givenname: Xun surname: Qu fullname: Qu, Xun |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23416968$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkV1rFDEUhoNU7LZ65b1EvCnIrPnO7I0gS1uFSr2o1yGTObNNmUmmSWZx_5Y_xN_kLF0X9eocOA8v7-E5QychBkDoNSVLSnj9wQ1-yQhlS6WfoQUjglWEMXWCFlRpVmlV01N0lvMDIbIWWrxAp4wLqlaqXiB_mwvEMYbiA85j7x3grU3ehpIx_BgT5Awtbna4SWBzwWUaYso4wWbqbQE8xBDdbl6sK35ri48Bb73FX9ffKoptaPHd9VX16yd9iZ53ts_w6jDP0fery7v15-rm9vrL-tNN5eZOuuKsk7phGhRdKdfKriNArRCEgnRcO6eYYExYaUkj9UoS4UjTKCW7Vimra36OPj7ljlMzQOsglGR7MyY_2LQz0Xrz7yX4e7OJWyMI4USyOeDiEJDi4wS5mMFnB31vA8QpG8qp0JTXVMzou__QhzilML9nmFazHCbJvtH7J8qlmHOC7liGErNXaGaFZq_QKD3Tb_7uf2T_OJuBt4e4-xg2jz5sjowQq1pxrflvcnmlFQ |
CitedBy_id | crossref_primary_10_3892_ijmm_2017_2964 crossref_primary_10_1016_j_canlet_2020_09_020 crossref_primary_10_1155_2016_7310694 crossref_primary_10_3389_fimmu_2023_1340634 crossref_primary_10_1016_j_prp_2022_153898 crossref_primary_10_1016_j_semcancer_2013_12_005 crossref_primary_10_1186_s12885_023_10854_x crossref_primary_10_1002_ijc_34457 crossref_primary_10_3390_ijms16010452 crossref_primary_10_1016_j_ijom_2021_07_022 crossref_primary_10_1155_2014_124063 crossref_primary_10_3390_cells11111808 crossref_primary_10_1113_EP085768 crossref_primary_10_4103_jmau_jmau_7_23 crossref_primary_10_1016_j_matbio_2014_03_001 crossref_primary_10_1186_s12943_023_01744_8 crossref_primary_10_1080_15476286_2018_1493328 crossref_primary_10_1177_0963689718756070 crossref_primary_10_1186_s12885_016_3024_4 crossref_primary_10_18632_oncotarget_13661 crossref_primary_10_1080_2162402X_2016_1256528 crossref_primary_10_1016_j_molmet_2015_07_010 crossref_primary_10_4049_jimmunol_2300063 |
Cites_doi | 10.1189/jlb.68.4.495 10.1126/science.287.5454.860 10.1371/journal.pone.0009633 10.1146/annurev.immunol.24.021605.090737 10.1002/art.24625 10.1038/nri978 10.1182/blood-2004-08-3228 10.1002/ijc.23204 10.1158/0008-5472.CAN-05-4005 10.1158/0008-5472.CAN-07-2126 10.1016/j.immuni.2008.05.008 10.1038/sj.onc.1209248 10.1016/j.ejca.2006.01.003 10.1002/path.1027 10.1016/j.jtcvs.2009.08.016 10.1074/jbc.M211074200 10.1007/s10555-007-9104-9 10.1093/carcin/bgi027 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A 10.1016/j.cytogfr.2008.08.001 10.1016/j.canlet.2008.07.004 10.1016/j.ejca.2004.03.016 10.1158/1541-7786.MCR-10-0463 10.1038/sj.onc.1200993 10.1016/S1471-4906(02)02302-5 10.4049/jimmunol.181.11.7480 10.1038/35006097 10.1091/mbc.e02-06-0354 10.1158/0008-5472.CAN-06-4763 |
ContentType | Journal Article |
Copyright | Chinese Society of Immunology and The University of Science and Technology 2013. Copyright © 2013 Chinese Society of Immunology and The University of Science and Technology 2013 Chinese Society of Immunology and The University of Science and Technology |
Copyright_xml | – notice: Chinese Society of Immunology and The University of Science and Technology 2013. – notice: Copyright © 2013 Chinese Society of Immunology and The University of Science and Technology 2013 Chinese Society of Immunology and The University of Science and Technology |
DBID | 2RA 92L CQIGP W91 ~WA CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1038/cmi.2012.67 |
DatabaseName | 维普_期刊 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Central Student |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Osteopontin splice variants expressed by breast tumors regulate monocyte activation via MCP-1 and TGF-β1 The effects of different OPN transcripts in tumorigenesis |
EISSN | 2042-0226 |
EndPage | 182 |
ExternalDocumentID | 10_1038_cmi_2012_67 23416968 44986377 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -05 -0E -Q- -SE -S~ 0R~ 29B 2B. 2C~ 2RA 2WC 3V. 4.4 406 53G 5GY 5VR 6J9 70F 7X7 88E 8FE 8FH 8FI 8FJ 92F 92I 92L 92M 93N 93R 9D9 9DE AADWK AANZL AATNV AAWBL AAYFA AAYJO AAZLF ABAWZ ABGIJ ABJNI ABKZE ABUWG ACAOD ACBMV ACBRV ACBYP ACGFS ACIGE ACKTT ACPRK ACRQY ACTTH ACVWB ACZOJ ADFRT ADHDB ADMDM ADQMX ADYYL AEDAW AEFTE AEJRE AENEX AEVLU AEXYK AFKRA AFNRJ AFSHS AFUIB AGAYW AGEZK AGGBP AGHAI AHMBA AHSBF AILAN AJCLW AJDOV AJRNO ALMA_UNASSIGNED_HOLDINGS AMRJV AMYLF AXYYD BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAJEE CAJUS CCEZO CCPQU CHBEP CIEJG CQIGP CW9 DIK DNIVK DPUIP DU5 EBLON EBS EE. EIOEI EJD F5P FA0 FDQFY FERAY FIZPM FRP FSGXE FYUFA GX1 HCIFZ HMCUK HYE HZ~ IWAJR JUIAU JZLTJ KQ8 LK8 M1P M7P NAO NQJWS NYICJ O9- OK1 P6G PQQKQ PROAC PSQYO Q-- Q-4 R-E RNT RNTTT RPM RT5 S.. SNX SNYQT SRMVM SWTZT T8U TAOOD TBHMF TCJ TDRGL TGQ TR2 TSG U1F U1G U5E U5O UKHRP W91 WFFXF ~88 ~MX ~WA AACDK AASML AAXDM ABAKF ABZZP AEFQL AEMSY AFBBN AGQEE AIGIU ALIPV CGR CUY CVF ECM EIF FIGPU NPM AAYXX CITATION 7XB 8FK AZQEC DWQXO GNUQQ K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c4167-32f57b27e6196cd5ff0e1a4401e5c37cc624224a5a0b579504c0bb665fd66a783 |
IEDL.DBID | RPM |
ISSN | 1672-7681 |
IngestDate | Tue Sep 17 21:22:53 EDT 2024 Sat Aug 17 01:12:04 EDT 2024 Fri Sep 13 01:56:37 EDT 2024 Thu Sep 26 15:57:52 EDT 2024 Sat Sep 28 07:53:32 EDT 2024 Wed Feb 14 10:44:28 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4167-32f57b27e6196cd5ff0e1a4401e5c37cc624224a5a0b579504c0bb665fd66a783 |
Notes | 11-4987/R alternative activation of monocytes; immune escape; OPN transcripts; MCP-1; TGF-I31 Osteopontin (OPN), a multifunctional glycoprotein, has three transcripts that have distinct roles in tumors in vitro. Whether OPN transcripts have different functions in tumor processes in vivo is unclear. It has been reported that immune cell-derived OPN can promote tumor formation. We propose a hypothesis that tumor-derived OPN may facilitate tumor immune escape by affecting immune cell differentiation and function. In this study, we constructed lentiviral expression vectors of OPN transcripts and transfected them into the MCF-7 cell line. MCF-7 cells transfected with OPN transcripts were injected into the armpit of nude mice, and tumor growth was monitored. The results showed that all OPN transcripts promoted local tumor formation, but that there was no significant difference among transcripts. We also investigated the effect of the OPN expressed by tumor cells on monocyte differentiation by coculturing monocytes with tumor supernatant. We found OPN-c upregulated CD163 levels compared with OPN-a and OPN-b; however, none of the transcripts affected HLA-DR and CD206 levels. All OPN transcripts significantly inhibited TNF-α and enhanced IL-10 production by monocytes. Furthermore, we found that the overexpression of OPN transcripts significantly upregulated TGF-β1 and MCP-1 production by tumor cells. Using neutralizing antibody and recombinant cytokines, we found that OPN overexpressed by tumor cells regulates the production of TNF-α and IL-10 by monocytes partly via MCP-1 and TGF-β1, respectively. Collectively, our results show that OPN transcripts have no distinct role in breast cancer formation in vivo. We also demonstrate that OPN regulates the alternative activation of monocytes via TGF-β1 and MCP-1, which may represent an additional mechanism for tumor immune escape. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.nature.com/articles/cmi201267.pdf |
PMID | 23416968 |
PQID | 2760382508 |
PQPubID | 2041960 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4003052 proquest_miscellaneous_1314713814 proquest_journals_2760382508 crossref_primary_10_1038_cmi_2012_67 pubmed_primary_23416968 chongqing_primary_44986377 |
PublicationCentury | 2000 |
PublicationDate | 2013-03-00 |
PublicationDateYYYYMMDD | 2013-03-01 |
PublicationDate_xml | – month: 03 year: 2013 text: 2013-03-00 |
PublicationDecade | 2010 |
PublicationPlace | China |
PublicationPlace_xml | – name: China – name: London |
PublicationTitle | Cellular & molecular immunology |
PublicationTitleAlternate | Cellular & Molecular Immunology |
PublicationYear | 2013 |
Publisher | Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group |
References | 9893260 - J Cell Biochem Suppl. 1998;30-31:92-102 15855273 - Blood. 2005 Aug 1;106(3):946-55 18172307 - Cancer Res. 2008 Jan 1;68(1):152-61 17545592 - Cancer Res. 2007 Jun 1;67(11):5141-7 17960616 - Int J Cancer. 2008 Feb 15;122(4):889-97 16551245 - Annu Rev Immunol. 2006;24:99-146 18049863 - Cancer Metastasis Rev. 2008 Mar;27(1):103-18 11037970 - J Leukoc Biol. 2000 Oct;68(4):495-502 21263033 - Mol Cancer Res. 2011 Mar;9(3):280-93 12529435 - Mol Biol Cell. 2003 Jan;14(1):173-89 12401408 - Trends Immunol. 2002 Nov;23(11):549-55 10746730 - Nature. 2000 Mar 23;404(6776):407-11 16288209 - Oncogene. 2006 Apr 6;25(15):2192-202 15251154 - Eur J Cancer. 2004 Jul;40(11):1660-7 12730217 - J Biol Chem. 2003 Aug 1;278(31):29086-97 18619869 - Immunity. 2008 Jul 18;29(1):68-78 10657301 - Science. 2000 Feb 4;287(5454):860-4 9129149 - Oncogene. 1997 Apr 3;14(13):1581-8 20224789 - PLoS One. 2010;5(3):e9633 16520032 - Eur J Cancer. 2006 Apr;42(6):717-27 19017937 - J Immunol. 2008 Dec 1;181(11):7480-8 19818970 - J Thorac Cardiovasc Surg. 2010 Jun;139(6):1587-93 9823334 - Cancer Res. 1998 Nov 15;58(22):5206-15 12511873 - Nat Rev Immunol. 2003 Jan;3(1):23-35 19565503 - Arthritis Rheum. 2009 Jul;60(7):1957-65 11857487 - J Pathol. 2002 Mar;196(3):254-65 9513730 - Biochem Soc Symp. 1998;63:273-94 16423985 - Cancer Res. 2006 Jan 15;66(2):605-12 18952487 - Cytokine Growth Factor Rev. 2008 Oct-Dec;19(5-6):333-45 18694621 - Cancer Lett. 2008 Dec 8;272(1):148-59 15661802 - Carcinogenesis. 2005 Apr;26(4):741-51 A Sica (BFcmi201267_CR22) 2006; 42 W Zheng (BFcmi201267_CR29) 2009; 60 MA Chellaiah (BFcmi201267_CR31) 2003; 14 D Courter (BFcmi201267_CR20) 2010; 5 MO Li (BFcmi201267_CR28) 2006; 24 MA Chellaiah (BFcmi201267_CR30) 2003; 278 DT Denhardt (BFcmi201267_CR1) 1998; 30–31 J Cheng (BFcmi201267_CR15) 2007; 67 B He (BFcmi201267_CR16) 2006; 25 JD Blasberg (BFcmi201267_CR18) 2010; 139 ML Shinohara (BFcmi201267_CR9) 2008; 29 A Mantovani (BFcmi201267_CR25) 2004; 40 A Mantovani (BFcmi201267_CR26) 2002; 23 G Murugaiyan (BFcmi201267_CR10) 2008; 181 M Mirza (BFcmi201267_CR17) 2008; 122 L Bingle (BFcmi201267_CR23) 2002; 196 AC Renkl (BFcmi201267_CR11) 2005; 106 H Chen (BFcmi201267_CR6) 1997; 14 TM Tilli (BFcmi201267_CR19) 2011; 9 M Gong (BFcmi201267_CR7) 2008; 272 HC Crawford (BFcmi201267_CR14) 1998; 58 PY Wai (BFcmi201267_CR2) 2008; 27 S Ashkar (BFcmi201267_CR12) 2000; 287 AW O'Regan (BFcmi201267_CR13) 2000; 68 PY Wai (BFcmi201267_CR8) 2005; 26 S Gordon (BFcmi201267_CR21) 2003; 3 CE Lewis (BFcmi201267_CR24) 2006; 66 KX Wang (BFcmi201267_CR3) 2008; 19 L Gu (BFcmi201267_CR27) 2000; 404 R Barraclough (BFcmi201267_CR5) 1998; 63 G Chakraborty (BFcmi201267_CR4) 2008; 68 |
References_xml | – volume: 68 start-page: 495 year: 2000 ident: BFcmi201267_CR13 publication-title: J Leukoc Biol doi: 10.1189/jlb.68.4.495 contributor: fullname: AW O'Regan – volume: 287 start-page: 860 year: 2000 ident: BFcmi201267_CR12 publication-title: Science doi: 10.1126/science.287.5454.860 contributor: fullname: S Ashkar – volume: 5 start-page: e9633 year: 2010 ident: BFcmi201267_CR20 publication-title: PLoS ONE doi: 10.1371/journal.pone.0009633 contributor: fullname: D Courter – volume: 24 start-page: 99 year: 2006 ident: BFcmi201267_CR28 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.24.021605.090737 contributor: fullname: MO Li – volume: 60 start-page: 1957 year: 2009 ident: BFcmi201267_CR29 publication-title: Arthritis Rheum doi: 10.1002/art.24625 contributor: fullname: W Zheng – volume: 3 start-page: 23 year: 2003 ident: BFcmi201267_CR21 publication-title: Nat Rev Immunol doi: 10.1038/nri978 contributor: fullname: S Gordon – volume: 106 start-page: 946 year: 2005 ident: BFcmi201267_CR11 publication-title: Blood doi: 10.1182/blood-2004-08-3228 contributor: fullname: AC Renkl – volume: 122 start-page: 889 year: 2008 ident: BFcmi201267_CR17 publication-title: Int J Cancer doi: 10.1002/ijc.23204 contributor: fullname: M Mirza – volume: 66 start-page: 605 year: 2006 ident: BFcmi201267_CR24 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-4005 contributor: fullname: CE Lewis – volume: 68 start-page: 152 year: 2008 ident: BFcmi201267_CR4 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-2126 contributor: fullname: G Chakraborty – volume: 29 start-page: 68 year: 2008 ident: BFcmi201267_CR9 publication-title: Immunity doi: 10.1016/j.immuni.2008.05.008 contributor: fullname: ML Shinohara – volume: 63 start-page: 273 year: 1998 ident: BFcmi201267_CR5 publication-title: Biochem Soc Symp contributor: fullname: R Barraclough – volume: 25 start-page: 2192 year: 2006 ident: BFcmi201267_CR16 publication-title: Oncogene doi: 10.1038/sj.onc.1209248 contributor: fullname: B He – volume: 42 start-page: 717 year: 2006 ident: BFcmi201267_CR22 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2006.01.003 contributor: fullname: A Sica – volume: 196 start-page: 254 year: 2002 ident: BFcmi201267_CR23 publication-title: J Pathol doi: 10.1002/path.1027 contributor: fullname: L Bingle – volume: 139 start-page: 1587 year: 2010 ident: BFcmi201267_CR18 publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2009.08.016 contributor: fullname: JD Blasberg – volume: 278 start-page: 29086 year: 2003 ident: BFcmi201267_CR30 publication-title: J Biol Chem doi: 10.1074/jbc.M211074200 contributor: fullname: MA Chellaiah – volume: 27 start-page: 103 year: 2008 ident: BFcmi201267_CR2 publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-007-9104-9 contributor: fullname: PY Wai – volume: 26 start-page: 741 year: 2005 ident: BFcmi201267_CR8 publication-title: Carcinogenesis doi: 10.1093/carcin/bgi027 contributor: fullname: PY Wai – volume: 58 start-page: 5206 year: 1998 ident: BFcmi201267_CR14 publication-title: Cancer Res contributor: fullname: HC Crawford – volume: 30–31 start-page: 92 year: 1998 ident: BFcmi201267_CR1 publication-title: J Cell Biochem Suppl doi: 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A contributor: fullname: DT Denhardt – volume: 19 start-page: 333 year: 2008 ident: BFcmi201267_CR3 publication-title: Cytokine Growth Factor Rev doi: 10.1016/j.cytogfr.2008.08.001 contributor: fullname: KX Wang – volume: 272 start-page: 148 year: 2008 ident: BFcmi201267_CR7 publication-title: Cancer Lett doi: 10.1016/j.canlet.2008.07.004 contributor: fullname: M Gong – volume: 40 start-page: 1660 year: 2004 ident: BFcmi201267_CR25 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2004.03.016 contributor: fullname: A Mantovani – volume: 9 start-page: 280 year: 2011 ident: BFcmi201267_CR19 publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-10-0463 contributor: fullname: TM Tilli – volume: 14 start-page: 1581 year: 1997 ident: BFcmi201267_CR6 publication-title: Oncogene doi: 10.1038/sj.onc.1200993 contributor: fullname: H Chen – volume: 23 start-page: 549 year: 2002 ident: BFcmi201267_CR26 publication-title: Trends Immunol doi: 10.1016/S1471-4906(02)02302-5 contributor: fullname: A Mantovani – volume: 181 start-page: 7480 year: 2008 ident: BFcmi201267_CR10 publication-title: J Immunol doi: 10.4049/jimmunol.181.11.7480 contributor: fullname: G Murugaiyan – volume: 404 start-page: 407 year: 2000 ident: BFcmi201267_CR27 publication-title: Nature doi: 10.1038/35006097 contributor: fullname: L Gu – volume: 14 start-page: 173 year: 2003 ident: BFcmi201267_CR31 publication-title: Mol Biol Cell doi: 10.1091/mbc.e02-06-0354 contributor: fullname: MA Chellaiah – volume: 67 start-page: 5141 year: 2007 ident: BFcmi201267_CR15 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-4763 contributor: fullname: J Cheng |
SSID | ssj0058474 |
Score | 2.153262 |
Snippet | Osteopontin (OPN), a multifunctional glycoprotein, has three transcripts that have distinct roles in tumors in vitro. Whether OPN transcripts have different... Osteopontin (OPN), a multifunctional glycoprotein, has three transcripts that have distinct roles in tumors in vitro. Whether OPN transcripts have different... Osteopontin (OPN), a multifunctional glycoprotein, has three transcripts that have distinct roles in tumors in vitro . Whether OPN transcripts have different... |
SourceID | pubmedcentral proquest crossref pubmed chongqing |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 176 |
SubjectTerms | Alternative splicing Animals Breast cancer Breast Neoplasms - genetics Breast Neoplasms - immunology Breast Neoplasms - pathology CD163 antigen Cell activation Cell differentiation Cell Line, Tumor Chemokine CCL2 - physiology Expression vectors Gene Expression Regulation, Neoplastic - immunology Genetic Variation - immunology Histocompatibility antigen HLA Humans IL-10 Immune Evasion - genetics Interleukin 10 MCP-1 Mice Mice, Nude Monocyte chemoattractant protein 1 Monocytes Monocytes - immunology Monocytes - metabolism Monocytes - pathology Osteopontin Osteopontin - biosynthesis Osteopontin - genetics RNA Splicing - genetics RNA Splicing - immunology TNF-α Transforming Growth Factor beta1 - physiology Transforming growth factor-b1 Tumor cells Tumor necrosis factor-α Tumors 乳腺肿瘤 单核细胞 变体 细胞活化 骨桥蛋白 |
SummonAdditionalLinks | – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwEB6VIkQviH9SCjJSr2Edx7GzJ4QqtiukAodW2lvkODbsocl2N1t1X6sP0mdixsmGLkhcokh24sSf7ZnxjOcDODbWc1XxcWz9mJJqexfnhuNFpqrCh7gPlCxn39T0Qn6dZbM9mG7PwlBY5XZNDAt11VjaIx8JrXiK5gzPR6akXQDbjj4trmLijyI_a0-m8QAeJgLVChzZejaYXuQLDP5lpVGfVHnSn9TDN47s5ZwivMRHopp_jGtO_fMKpcaunPpH-fw7hvKeUJo8hSe9Nsk-d_A_gz1XP4dHHb_k5gXMvyOGzaIhNgi2Ik-1Y9doHFPsC3M3IQbWVazcsJJi01vWri-b5YotO4J6x_BXG7vBGzr-0G3esuu5YWcnP-KEmbpi56eT-O42eQkXky_nJ9O451aIraRU56lAEEqhHRpQylaZ99wlRqK15TKbamvp3IiQJjO8zPQ449LyslQq85VSRufpK9ivm9q9AWa0S7y3lVfKSfLaKeGEx2a8z5XLkggOh14tFl0OjULKca5SrSM43nbzUBb84mleIDIFIVMorHa0haDoJ9mq-DMkIvgwFOP0IJ-HqV2zXhVJmqD4RbVERvC6Q2xoR6AEp9xAEegdLIcKlHp7t6Se_wopuGWwvcTh_z_rLRyIwJ5BIWtHsN8u1-4d6jBt-T4Mz9_xaPMO priority: 102 providerName: ProQuest |
Title | Osteopontin splice variants expressed by breast tumors regulate monocyte activation via MCP-1 and TGF-β1 |
URI | http://lib.cqvip.com/qk/87787X/201302/44986377.html https://www.ncbi.nlm.nih.gov/pubmed/23416968 https://www.proquest.com/docview/2760382508/abstract/ https://search.proquest.com/docview/1314713814 https://pubmed.ncbi.nlm.nih.gov/PMC4003052 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED_ajsFexr7nrgsa9NWJLcmS87iFZmWQLowW8mZkWVoNi53lozT_Vv-Q_U07yR8s29tejEESMncn3Z3vd3cA50rbSBTRONR27IpqWxOmKsIHZ6LARZH1LVlmV-Lyhn9ZJIsjSLpcGA_a13k5rH4sh1V567GVq6UedTix0Xw24d7ypaNjOJaMdS56c_26sJ8PJQuJpqNI4zYpL2LpSC9LB-aiQ-F671G8wF1pGFdV4bauvv9EXXGonf4xOf9GTv6hiqbP4GlrQ5KPzbc-hyNTvYDHTVfJ_UsovyLn6lXtekCQjYtPG3KHLrFDvBBz75GvpiD5nuQOkb4l292yXm_IumlLbwhKZq33-OKSHppftuSuVGQ2mYcxUVVBrj9Pw18P8Su4mV5cTy7DtqNCqLkrcM4okj6n0qDbJHSRWBuZWHH0sUyimdTaZYtQrhIV5YkcJxHXUZ4LkdhCCCVT9hpOqroyb4EoaWJrdWGFMNzF6gQ11OI21qbCJHEApz1Vs1VTOSPjfJwKJmUA5x2Z-zEfDWdphkzKHJMygdPOOhZk7dHaZFQKnIaWWxrAh34YD4WLdKjK1LtNFrMYlS4aIzyANw3H-n06tgcgD3jZT3AFtw9HUA594e1W7k7_e-U7eEJ9Ow2HYTuDk-16Z96jUbPNByjKCzmAR58urubfBl6kfwMOsPqz |
link.rule.ids | 230,315,733,786,790,891,12083,21416,27957,27958,31754,31755,33779,33780,43345,43840,53827,53829,74102,74659 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fb9MwELdgCI2Xif9kG2CkvYY5tmOnTxOaVgqsg4dO6lvkODb0YUnXtBP9WvsgfCbunDSjIPESRbITJz7bd-f7-X6EHBnrmSrZILZ-gEm1vYszw-AihSrhIeYDJcv4Qo0u5edpOu023JoOVrlZE8NCXdYW98iPuVZMgDvDspP5dYysURhd7Sg07pMHUgiJkD497R0ujACGqLLSYEWqLOnO58F7ju3VDHFd_D0SzO_CSlN9vwZdsa2d_jE5_0ZO_qGKho_JXmdD0g-t0J-Qe656Sh62rJLrZ2T2FSRXz2vkgKANxqcdvQGXGBEv1P0MyFdX0mJNC0SkL-lydVUvGrpoaekdhV-t7Rpu8NBDu2VLb2aGjk-_xQk1VUknH4fxr9vkObkcnk1OR3HHqBBbiQnOBYeuL7h24DYpW6beM5cYCT6WS63Q1uJpES5NaliR6kHKpGVFoVTqS6WMzsQLslPVlXtFqNEu8d6WXiknMVanuOMemvE-Uy5NIrLf92o-bzNn5FIOMiW0jsjRppv7shANF1kOkslRMrmCaocbEeTd1Gryu4EQkXd9MUwKjHSYytWrJk9EAkoXjBEZkZetxPp2OOhtzAgUEb0ly74CJtzeLqlmP0LibRk8Lr7__896S3ZHk_F5fv7p4ssBecQDfwaC1g7JznKxcq_BilkWb8JQ_Q3l4_JB |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BEY8L4lVIKWCkXsM6jmNnTwgVlvJo6aGV9hY5jg17aLLd7Fbs3-KH8JuYcbKBBYlLFMlOnHhsz4zn83wAB8Z6rio-jq0fU1Jt7-LccLzIVFX4EPeBkuX4RB2dy4_TbNrjn9oeVrlZE8NCXTWW9shHQiueojvD85HvYRGnbyev55cxMUhRpLWn07gON1BLcmIz0NPB-aJoYIgwK40WpcqT_qwevnNkL2aE8RKviGz-Nq469ddL1Bvbmuof8_NvFOUfamlyD-729iR70w2A-3DN1Q_gZscwuX4Isy8oxWbeEB8EaylW7dgVuseEfmHue0DBuoqVa1YSOn3JlquLZtGyRUdR7xj-amPXeEMHILrtW3Y1M-z48DROmKkrdvZ-Ev_8kTyC88m7s8OjuGdXiK2kZOepQDGUQjt0oZStMu-5S4xEf8tlNtXW0skRIU1meJnpccal5WWpVOYrpYzO013YqZvaPQFmtEu8t5VXykmK2ynhhMdmvM-Vy5II9oZeLeZdFo1CynGuUq0jONh081AWIuNpXqBkCpJMobDa_kYERT_N2uL3oIjg5VCME4SiHqZ2zaotkjRBBYyGiYzgcSexoR2BOpyyA0Wgt2Q5VKDk29sl9exbSMItg_cl9v7_WS_gFo7S4vOHk09P4Y4IVBqEX9uHneVi5Z6hQbMsn4eR-gsHWvZt |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Osteopontin+splice+variants+expressed+by+breast+tumors+regulate+monocyte+activation+via+MCP-1+and+TGF-%CE%B21&rft.jtitle=Cellular+%26+molecular+immunology&rft.au=Sun%2C+Jintang&rft.au=Feng%2C+Alei&rft.au=Chen%2C+Songyu&rft.au=Zhang%2C+Yun&rft.date=2013-03-01&rft.eissn=2042-0226&rft.volume=10&rft.issue=2&rft.spage=176&rft_id=info:doi/10.1038%2Fcmi.2012.67&rft_id=info%3Apmid%2F23416968&rft.externalDocID=23416968 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F87787X%2F87787X.jpg |